Androgen imbalance in premenopausal women with benign breast disease and breast cancer

Clinical Biochemistry

Volumn 32, Issue 5, 1999, Pages 375-380

  Lee, Seon Hwa ^a   Kim, Soon Ok ^b   Kwon, Sung Won ^c   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Sungshin Women's University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Andregens; Benign breast disease; Breast cancer; Corticoids; Gas chromatography mass spectrometry

Indexed keywords

17 HYDROXYCORTICOSTEROID; ANDROGEN; CORTICOSTEROID; HYDROCORTISONE; OXOSTEROID;

ADULT; ANDROGEN METABOLISM; ARTICLE; BREAST CANCER; BREAST DISEASE; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GAS CHROMATOGRAPHY; HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLITE; PREMENOPAUSE; PRIORITY JOURNAL; URINARY EXCRETION;

ADRENAL CORTEX HORMONES; ANDROGENS; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; KETOSTEROIDS; MENOPAUSE;

EID: 0009018821     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00028-4     Document Type: Article

References (21)

1. Schneider J., Kime D., Frachia A., et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA. 79:1982;3047-3051.
2. Ursin G., London S., Stanczyk F.Z., et al. A pilot study of urinary estrogen metabolites (16α-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ Health Perspect. 105:1997;601-605.
3. Kabat G.C., Chang C.J., Sparano J.A., et al. Urinary estrogen metabolites and breast cancer a case-control study . Cancer Epidemiol Biomark Prev. 6:1997;505-509.
4. Lee S.H., Kim S.O., Lee H.D., Chung B.C. Estrogens and polyamines in breast cancer their profiles and values in disease staging . Cancer Lett. 133:1998;47-56.
5. Bulbrook R.D., Thomas B.S. Hormones are ambiguous risk factors for breast cancer. Acta Oncologica. 28:1989;841-847.
6. Swain M.C., Hayward J.L., Bulbrook R.D. Plasma oestradiol and progesterone in benign breast disease. Eur J Cancer. 9:1973;553-556.
7. Hackenberg R., Schulz K.D. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen-and androgen-like steroids. J Steroid Biochem Mol Biol. 56:1996;113-117.
8. Szelei J., Jimenez J., Soto A.M., Luizzi M.F., Sonnenschein C. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology. 138:1997;1406-1412.
9. Cameron E.D.H., Griffiths K., Gleave E.N., Stewart H.J., Forrest A.P.M., Campbell H. Benign and malignant breast disease in South Wales a study of urinary steroids . Br Med J. 4:1970;768-771.
10. Argülles A.E., Poggi U.L., Saborida C., Hoffman C., Chekherdemian M., Blanchard O. Endocrine profiles and breast cancer. Lancet. 1:1973;165-168.
11. Kodama M., Kodama T., Yoshida M., Totania R., Aoki K. Hormonal status of breast cancer. II. Abnormal urinary steroid excretion. J Natl Cancer Inst. 54:1975;1275-1282.
12. Bernstein L., Ross R.K. Endogenous hormones and breast cancer risk. Epidemiol Rev. 15:1993;48-65.
13. Lee S.H., Choi M.H., Kim T.W., Chung B.C. Evaluation of endogenous steroids profile after administration of anabolic steroids. J Korean Chem Soc. 41:1997;406-413.
14. Zumoff B. Hormonal profiles in woman with breast cancer (review). Anticancer Res 1988; 8: 627-36.
15. Allen B.J., Hayward J.L., Merivale W.H.H. The excretion of 17-ketosteroids in the urine of patients with generalized carcinomatosis secondary to carcinoma of the breast. Lancet. 1:1957;496-499.
16. Bulbrook R.D., Hayward J.L., Spicer C.C. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 2:1971;395-398.
17. Miller H., Durant J.A. The value of urine steroid hormone assays in breast cancer. Clin Biochem. 1:1968;287-298.
18. Kumaoka S., Sakauchi N., Abe O., Kusama M., Takatani O. Urinary 17-ketosteroid excretion of women with advanced breast cancer. J Clin Endocr. 28:1968;667-672.
19. Rohan T.E., Hartwick W., Miller A.B., Kandel R.A. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. J Natl Cancer Inst. 90:1998;1262-1269.
20. Stomper P.C., DeBloom J.R. 2nd, Budnick R.M., Stewart C.C. Flow cytometric DNA analyses of benign breast lesions detected by screening mammography. Clin Cancer Res. 4:1998;1543-1547.
21. Black M.M., Barclay T.H.C., Cutler S.S., Hankey B.F., Asire A.J. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer. 29:1972;338.